ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,035Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 336

$960K Total Retail Price of All Prescriptions

Rank: 45 out of 336

621 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 621 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 11,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
ATORVASTATIN CALCIUM 831 654 1 14
AMLODIPINE BESYLATE 609 510 2 1
PRAVASTATIN SODIUM 554 437 3 10
LISINOPRIL 492 373 4 6
OMEPRAZOLE 483 352 5 3
LEVOTHYROXINE SODIUM 472 419 6 7
METFORMIN HCL 353 245 7 8
FUROSEMIDE 346 256 8 4
POTASSIUM CHLORIDE 327 228 9 9
CARVEDILOL 278 204 10 13
GABAPENTIN 256 174 11 11
HYDROCHLOROTHIAZIDE 219 179 12 12
HYDROCODONE-ACETAMINOPHEN 219 157 S3 12 2
WARFARIN SODIUM 210 163 14 17
TRAMADOL HCL 208 183 15 20
LIPITOR 190 138 16 62
METOPROLOL TARTRATE 187 147 17 16
ATENOLOL 182 157 18 26
MELOXICAM 174 153 19 19
NEXIUM 171 148 20 24
ALLOPURINOL 171 128 20 30
CLOPIDOGREL 167 134 22 28
DIOVAN 165 134 23 31
CRESTOR 154 125 24 25
METOPROLOL SUCCINATE 152 115 25 15
HYDRALAZINE HCL 142 122 26 53
SIMVASTATIN 140 135 27 5
ZOLPIDEM TARTRATE 138 124 28 18
PLAVIX 138 123 28 37
INSULIN SYRINGE 135 100 30 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 104 31 23
LOSARTAN POTASSIUM 130 97 32 22
CLONIDINE HCL 125 77 33 32
DONEPEZIL HCL 123 123 34 27
ESCITALOPRAM OXALATE 123 90 34 69
GLIPIZIDE 112 92 36 71
BENAZEPRIL HCL 104 81 37 59
GLYBURIDE 100 88 R 38 76
ALENDRONATE SODIUM 97 94 39 54
KLOR-CON 10 97 93 39 75
LYRICA 95 65 41 70
SERTRALINE HCL 93 79 42 33
BYSTOLIC 91 75 43 79
AMLODIPINE BESYLATE-BENAZEPRIL 90 75 44 47
TRICOR 89 62 45 108
HUMALOG MIX 75-25 87 66 46 264
JANUVIA 83 35 47 67
KLOR-CON M20 81 57 48 51
GLIMEPIRIDE 80 63 49 29
TRIAMTERENE-HCTZ 78 78 50 35
DIGOXIN 78 70 50 50
KLOR-CON 8 72 67 52 237
FLUTICASONE PROPIONATE 72 45 52 49
NOVOLOG MIX 70-30 68 45 54 189
ADVAIR DISKUS 67 43 55 82
HUMULIN 70-30 65 32 56 173
GLIPIZIDE XL 63 54 57 174
ISOSORBIDE MONONITRATE ER 61 54 58 44
LOSARTAN-HYDROCHLOROTHIAZIDE 60 57 59 45
AMITRIPTYLINE HCL 59 41 R 60 57
CIPROFLOXACIN HCL 59 40 60 55
RAMIPRIL 58 36 62 84
PREDNISONE 57 51 63 48
NAMENDA 56 52 64 39
CITALOPRAM HBR 55 50 65 21
ONGLYZA 52 49 66 165
PROPRANOLOL HCL 52 52 66 101
DIOVAN HCT 52 48 66 41
VENLAFAXINE HCL ER 51 27 69 100
BENICAR 50 42 70 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.